Safety of Polypharmacy with Frequent Dose Changes

Primary Safety Concerns

• Elderly patients with cardiovascular disease, diabetes, and hypertension taking multiple medications have a higher risk of severe drug-drug interactions and all-cause mortality, with the European Society of Cardiology recommending careful management of polypharmacy 1, 2
• The American Geriatrics Society suggests that elderly patients taking 5 or more medications have a higher risk of inappropriate polypharmacy, including overuse, underuse, misuse, and harmful drug combinations 1
• Over one-fifth of older people with multimorbidity receive medications that adversely affect coexisting conditions, according to the European Heart Journal 3
• Patients taking 5 or more medications average one significant drug problem per regimen, highlighting the need for regular medication review, as recommended by the Mayo Clinic 2

Age-Related Vulnerabilities Amplifying Risk

• Aging produces decreased renal clearance, reduced hepatic metabolism, and altered body composition, requiring dose adjustments that are frequently overlooked, as noted by the European Heart Journal 4, 5
• Serum creatinine-based equations misclassify kidney disease by one stage in over 30% of elderly patients, leading to inappropriate dosing of renally cleared drugs, according to the European Heart Journal 4
• CKD-EPI creatinine-cystatin C equations are more accurate than creatinine-based formulas alone in older people, yet are underutilized, as reported by the European Heart Journal 4

Specific Risks with Frequent Dose Changes

• Frequent dose adjustments of cardiovascular medications compound risk by creating periods of hemodynamic instability before steady-state is achieved, as warned by the European Heart Journal 1
• Taking 7 or more drugs increases 30-day unplanned rehospitalization risk nearly 4-fold, highlighting the need for careful medication management, as reported by the Mayo Clinic 2
• Fall risk increases 21% with 4+ medications and 50% with 10+ medications in elderly patients, emphasizing the importance of monitoring and prevention strategies, as recommended by the Mayo Clinic 2

Critical Management Strategies

• Implement a multidisciplinary team approach involving cardiologists, pharmacists, nurses, and social workers to coordinate medication management and prevent discrepancies in goals of care, as suggested by the European Heart Journal 3, 9
• Systematically review all medications for necessity, effectiveness, and potential interactions at every encounter, particularly before and after dose changes, as recommended by the European Heart Journal and Praxis Medical Insights 7
• Deprescribe unnecessary medications to reduce polypharmacy burden, as structured medication reviews can reduce adverse effects and improve health outcomes, according to Praxis Medical Insights 7
• Monitor blood pressure and heart rate at every dose change of cardiovascular medications, particularly beta-blockers and antihypertensives, as advised by Praxis Medical Insights 7
• Assess renal function using CKD-EPI creatinine-cystatin C equations before initiating or adjusting doses of renally cleared drugs, as recommended by the European Heart Journal and Praxis Medical Insights 4, 7
• Prioritize goals of preserving quality of life, maintaining functional capacity, controlling symptoms, and reducing treatment burden over life extension alone, as suggested by the European Heart Journal 9
• Educate patients on signs of adverse drug reactions specific to their regimen, including dizziness, falls, confusion, bleeding, and muscle pain, as recommended by Praxis Medical Insights 7
• Simplify medication regimens whenever possible by using combination products, once-daily formulations, and eliminating duplicative therapies, as advised by the Mayo Clinic 2
• Coordinate care across transitions between emergency departments, inpatient units, and outpatient settings, as elderly patients are most vulnerable during these periods, according to the European Heart Journal 9